Caponnetto Pasquale, DiPiazza Jennifer, Kim Jason, Maglia Marilena, Polosa Riccardo
Department of Educational Science, University of Catania, Catania, Italy.
Faculty of Health Science and Sport, University of Stirling, Stirling, UK.
Nicotine Tob Res. 2021 Jun 8;23(7):1113-1122. doi: 10.1093/ntr/ntab005.
An estimated 60%-90% of people with schizophrenia smoke, compared with 15%-24% of the general population, exacerbating the already high morbidity and mortality rates observed in this population.
This study aimed to assess the feasibility of using a new-generation high strength nicotine e-cigarette to modify smoking behavior in individuals with schizophrenia spectrum disorders who smoke cigarettes. A single-arm pilot study was conducted with 40 adults with schizophrenia spectrum disorders who smoked and did not intend to reduce or quit smoking. Participants were given a 12-week supply of a JUUL e-cigarette loaded with a 5% nicotine pod. The primary outcome was smoking cessation at week 12. Additional outcomes included: smoking reduction, continuous abstinence at week 24, adoption rate, adherence to the e-cigarette, feasibility, acceptability, and subjective effects.
Sixteen (40%) participants quit by the end of 12 weeks. For the whole sample, we observed an overall, sustained 50% reduction in smoking or smoking abstinence in 37/40 (92.5%) of participants and an overall 75% reduction in median cigarettes per day from 25 to six was observed by the end of the 12 weeks (p < .001).
A high strength nicotine e-cigarette has the potential to help people with schizophrenia spectrum disorders to quit or reduce smoking. Further research with a larger sample and a comparator group is needed. The results provide useful information and direction to augment the existing body of knowledge on smoking cessation for people with schizophrenia spectrum disorders.
Considering that most people with schizophrenia spectrum disorders continue smoking, alternative and efficient interventions to reduce or prevent morbidity and mortality are urgently needed. This study showed that adults who smoke and were not motivated to quit, when provided a new-generation e-cigarette with high nicotine content, demonstrated substantially decreased cigarette consumption without causing significant side effects. Although not specifically measured in this study, nicotine absorption in new-generation devices has been shown to be consistently superior compared with the first generation of e-cigarette devices, and this may help explain the lower quit rates in studies using earlier generation devices.
据估计,60%-90%的精神分裂症患者吸烟,而普通人群的吸烟率为15%-24%,这加剧了该人群本就较高的发病率和死亡率。
本研究旨在评估使用新一代高强度尼古丁电子烟来改变吸烟的精神分裂症谱系障碍患者吸烟行为的可行性。对40名吸烟且不打算减少或戒烟的成年精神分裂症谱系障碍患者进行了一项单臂试点研究。参与者获得了为期12周的装有5%尼古丁烟弹的JUUL电子烟。主要结局是第12周时戒烟。其他结局包括:减少吸烟量、第24周时持续戒烟、采用率、对电子烟的依从性、可行性、可接受性和主观效果。
16名(40%)参与者在12周结束时戒烟。对于整个样本,我们观察到37/40(92.5%)的参与者吸烟量总体持续减少50%或戒烟,到12周结束时,每天吸烟中位数从25支降至6支,总体减少了75%(p <.001)。
高强度尼古丁电子烟有可能帮助精神分裂症谱系障碍患者戒烟或减少吸烟。需要对更大样本和对照组进行进一步研究。这些结果为扩充现有的关于精神分裂症谱系障碍患者戒烟的知识体系提供了有用的信息和方向。
鉴于大多数精神分裂症谱系障碍患者继续吸烟,迫切需要替代性的有效干预措施来降低或预防发病率和死亡率。本研究表明,吸烟且没有戒烟意愿的成年人,在使用高尼古丁含量的新一代电子烟时,香烟消费量大幅下降,且未产生明显副作用。尽管本研究未进行具体测量,但与第一代电子烟设备相比,新一代设备中的尼古丁吸收一直表现更优,这可能有助于解释使用早期一代设备的研究中戒烟率较低的原因。